Annotation Detail

Information
Associated Genes
PML
Associated Variants
PML PML-RARA
Associated Disease
acute promyelocytic leukemia
Source Database
CIViC Evidence
Description
A 39-year old woman who presented with acute myeloid leukemia revealed a complicated genetic profile using conventional metaphase cytogenetics and FISH analysis. Whole genome sequencing elucidated a PML-RARA fusion, which can be successfully treated with ATRA. Uncovering this mutation prevented an unnecessary allogeneic transplant and the patient remained in remission 15 months post-treatment (date of publication).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1519
Gene URL
https://civic.genome.wustl.edu/links/genes/39
Variant URL
https://civic.genome.wustl.edu/links/variants/108
Rating
3
Evidence Type
Predictive
Disease
Acute Promyelocytic Leukemia
Evidence Direction
Supports
Drug
Tretinoin
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
21505136
Drugs
Drug NameSensitivitySupported
TretinoinSensitivitytrue